|
Cao, Deliang; Ziemba, Amy; McCabe, James et al. (2011) Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity. Mol Cancer Ther 10:2330-9
|
|
Wan, Laxiang; Cao, Deliang; Zeng, Jianmin et al. (2006) Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells. Mol Pharmacol 69:1389-95
|
|
Cao, Deliang; Leffert, Janine J; McCabe, James et al. (2005) Abnormalities in uridine homeostatic regulation and pyrimidine nucleotide metabolism as a consequence of the deletion of the uridine phosphorylase gene. J Biol Chem 280:21169-75
|
|
Pizzorno, Giuseppe; Cao, Deliang; Leffert, Janine J et al. (2002) Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update. Biochim Biophys Acta 1587:133-44
|
|
Cao, Deliang; Russell, Rosalind L; Zhang, Dekai et al. (2002) Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines. Cancer Res 62:2313-7
|
|
Zhang, D; Cao, D; Russell, R et al. (2001) p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction. Cancer Res 61:6899-905
|
|
Cao, D; Nimmakayalu, M A; Wang, F et al. (1999) Genomic structure, chromosomal mapping, and promoter region analysis of murine uridine phosphorylase gene. Cancer Res 59:4997-5001
|
|
Liu, M; Cao, D; Russell, R et al. (1998) Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors. Cancer Res 58:5418-24
|
|
Pizzorno, G; Yee, L; Burtness, B A et al. (1998) Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor. Clin Cancer Res 4:1165-75
|
